Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Strandhave

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Journal of Nephrology|April 11, 2013
Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney diseaseCharlotte Strandhave, My Svensson, Henrik Krarup, et al.
The British Journal of Nutrition|July 28, 2011
Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patientsEllen Kirkegaard, My Svensson, Charlotte Strandhave, et al.
Nutrition Research (New York, N.Y.)|March 15, 2017
Marine n-3 polyunsaturated fatty acids affect the blood pressure control in patients with newly diagnosed hypertension - a 1-year follow-up studyCarina N Bagge, Charlotte Strandhave, Charlotte M Skov, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 17, 2015
The Effect of n-3 Fatty Acids on Small Dense Low-Density Lipoproteins in Patients With End-Stage Renal Disease: A Randomized Placebo-Controlled Intervention StudyGustav V B Sørensen, My Svensson, Charlotte Strandhave, et al.
Basic & Clinical Pharmacology & Toxicology|February 3, 2024
Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimizationNiels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, et al.
Ugeskrift for Laeger|March 18, 2014
[Participation in dinner at a medical conference reduces vascular age and is recommended]Kristian Nebelin Hvidt, Charlotte Strandhave, Esben Laugesen, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 21, 2023
No Detectable Coagulation Activation After Vitamin K (MK-7) Supplementation in Patients on Dialysis With Functional Vitamin K Deficiency: A One-Year Randomized, Placebo-Controlled StudyElse-Marie Bladbjerg, Karin Levy-Schousboe, Marie Frimodt-Møller, et al.
Plos One|June 2, 2015
Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study)Christian Daugaard Peters, Krista Dybtved Kjaergaard, Jens Dam Jensen, et al.
Ugeskrift for Laeger|April 29, 2022
[SGLT2 inhibitorsfor treatment of chronic kidney disease without diabetes or heart failure]Bo Feldt-Rasmussen, Rikke Borg, Jan Carstens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 11, 2016
Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort studyEva Futtrup Maksten, Maja Ølholm Vase, Jan Kampmann, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Nephrology|April 11, 2013
Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney diseaseCharlotte Strandhave, My Svensson, Henrik Krarup, et al.
The British Journal of Nutrition|July 28, 2011
Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patientsEllen Kirkegaard, My Svensson, Charlotte Strandhave, et al.
Nutrition Research (New York, N.Y.)|March 15, 2017
Marine n-3 polyunsaturated fatty acids affect the blood pressure control in patients with newly diagnosed hypertension - a 1-year follow-up studyCarina N Bagge, Charlotte Strandhave, Charlotte M Skov, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 17, 2015
The Effect of n-3 Fatty Acids on Small Dense Low-Density Lipoproteins in Patients With End-Stage Renal Disease: A Randomized Placebo-Controlled Intervention StudyGustav V B Sørensen, My Svensson, Charlotte Strandhave, et al.
Basic & Clinical Pharmacology & Toxicology|February 3, 2024
Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimizationNiels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, et al.
Ugeskrift for Laeger|March 18, 2014
[Participation in dinner at a medical conference reduces vascular age and is recommended]Kristian Nebelin Hvidt, Charlotte Strandhave, Esben Laugesen, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 21, 2023
No Detectable Coagulation Activation After Vitamin K (MK-7) Supplementation in Patients on Dialysis With Functional Vitamin K Deficiency: A One-Year Randomized, Placebo-Controlled StudyElse-Marie Bladbjerg, Karin Levy-Schousboe, Marie Frimodt-Møller, et al.
Plos One|June 2, 2015
Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study)Christian Daugaard Peters, Krista Dybtved Kjaergaard, Jens Dam Jensen, et al.
Ugeskrift for Laeger|April 29, 2022
[SGLT2 inhibitorsfor treatment of chronic kidney disease without diabetes or heart failure]Bo Feldt-Rasmussen, Rikke Borg, Jan Carstens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 11, 2016
Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort studyEva Futtrup Maksten, Maja Ølholm Vase, Jan Kampmann, et al.
Pageof 2